Logo

American Heart Association

  25
  0


Final ID:

Lipid Metabolism in PAH: A Driver of Vascular Dysfunction?

  • Chan, Stephen  ( UNIVERSITY OF PITTSBURGH , Pittsburgh , Pennsylvania , United States )
  • Michelakis, Evangelos  ( University of Alberta , Edmonton , Alberta , Canada )
  • Brittain, Evan  ( VANDERBILT UNIVERSITY , Nashville , Tennessee , United States )
  • Author Disclosures:
    Stephen Chan: DO have relevant financial relationships ; Research Funding (PI or named investigator):WoodNext Foundation:Active (exists now) ; Employee:University of Pittsburgh/UPMC:Active (exists now) ; Ownership Interest:Amlysion Therapeutics:Active (exists now) ; Ownership Interest:Synhale Therapeutics:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:United Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Bayer:Past (completed) ; Research Funding (PI or named investigator):United Therapeutics:Active (exists now) | Evangelos Michelakis: No Answer | Evan Brittain: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Metabolic Dysregulation in PAH – From Lipids to Amino Acids

Saturday, 11/08/2025 , 03:15PM - 04:30PM

Cardiovascular Seminar

More abstracts on this topic:
Mitochondrial Dysfunction in PAH: A Targetable Vulnerability?

Rafikov Ruslan, Michelakis Evangelos, Archer Stephen

Metabolic Reprogramming in Right Ventricular Failure: Adaptive or Maladaptive?

Hemnes Anna, Umar Soban, Bogaard Harm

You have to be authorized to contact abstract author. Please, Login
Not Available